Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Evaluation of Clinical and Radiographic Success of Oxymetazoline Versus Sodium Hypochlorite as Hemostatic Agents in MTA Pulpotomy of Primary Molars in a Group of Egyptian Children: A Randomized Controlled Trial

NCT07675330 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT07675330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07675330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Evaluation of Clinical and Radiographic Success of Oxymetazoline Versus Sodium Hypochlorite as Hemostatic Agents in MTA Pulpotomy of Primary Molars in a Group of Egyptian Children: A Randomized Controlled Trial
Lead sponsor
Cairo University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
December 31, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carious exposure of pulp, primary molar pulpotomy, primary molar tooth, pulp disease, dental, pulp inflammation, pulp therapy in primary molars, pulpitis - reversible, vital pulp therapies